Company: LRHC
Filing Date: 2025-09-30
Form Type: 424B3
Source: 0001213900-25-093998
Chunk: 30

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-30
Form: 424B3
Chunk 30
---
 right to sell the full Commitment Amount (as defined below) to the Selling Stockholder. As of September 24, 2025, there were 1,224,640 shares
of common stock outstanding, and therefore the Exchange Cap is 244,805 shares of common stock. the Selling Stockholder will not be
required to subscribe for any shares of common stock under the Facility which, when aggregated with all other shares of common stock then
beneficially owned by the Selling Stockholder and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act, and Rule
13d-3 promulgated thereunder), would result in the beneficial ownership by the Selling Stockholder and its affiliates to exceed 4.99%
(which the Selling Stockholder, upon notice to the Company, may increase or decrease but in no event in excess of 9.99%) of the outstanding
voting power or number of the common stock.

If, following satisfaction of the conditions set forth in the Facility,
we elect to sell to the Selling Stockholder all of Shares being registered for resale hereunder, depending on the market prices of our
common stock at the time of such sales, the gross proceeds from such sales of all such shares of common stock by us to the Selling Stockholder
may be substantially less than the $1,000,000,000 total purchase commitment available to us under the Facility, which could materially
adversely affect our liquidity.

If it becomes necessary for us to issue and sell to the Selling Stockholder
shares of common stock in excess of the Exchange Cap under the Facility in order to receive additional gross proceeds up to $1,000,000,000
under the Facility, then for so long as the Exchange Cap continues to apply to the issuances and sales of our common stock under the Facility,
we must first obtain stockholder approval to issue shares of common stock in excess of the Exchange Cap in accordance with the applicable
Nasdaq listing rules. Any issuance and sale by us under the Facility of shares of common stock in excess of the Exchange Cap could cause
additional substantial dilution to our stockholders. The number of shares of our common stock ultimately offered for sale by the Selling
Stockholder is dependent upon the number of shares of common stock, if any, we ultimately sell to the Selling Stockholder under the Facility,
and the sale of common stock under the Facility may cause the trading price of our common stock to decline.

Investors who buy shares at different times